Relmada Therapeutics Inc
Biotechnology
Healthcare
RLMD
33.19 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.65
52 week high
1.67
high
1.75
52 week low
0.00
previous Close
1.65
P/E ratio
market cap
47.13 M
div yield
0
net incoming
-9.87 M
43.81 %
net profit margin
-986644200.00 %
0.00 %
operating incoming
-10.22 M
43.89 %
net change in cash
204 K
107.52 %
cash on hand
1.35 M
17.71 %
top